News

Big pharma lacking in new antibiotic patents


TRY IT NOW

Sign up online today & collaborate

or click here to find out more

Big pharma lacking in new antibiotic patents


Date: 17/06/2015

The antibiotics market is at risk of losing another decade to inadequate levels of research and innovation in favour of rare disease drugs, according to a new study.

A report from intellectual property firm Marks & Clarke looked at patent trends over the last decade and found that less than 5% of antibiotic patents filed since 2004 were for new classes of drugs in this area.

For more click here

Source: Pharma Times

© Catalyst Innovation Portal 2019